Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bayer says to appeal U.S. court ruling on PCBs if necessary

Published 07/28/2021, 05:19 AM
Updated 07/28/2021, 05:51 AM
© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo

FRANKFURT (Reuters) - German chemicals maker Bayer (OTC:BAYRY) said on Wednesday it may appeal an order in a U.S. legal case to pay $185 million to four staff members of a school in the state of Washington over exposure to polychlorinated biphenyls, or PCBs, made by the former Monsanto (NYSE:MON) Co.

Bayer, which bought Monsanto for $63 billion in 2018, said it disagreed with the verdict and planned to pursue post-trial motions and, if necessary, an appeal.

"The undisputed evidence in this case does not support the conclusions that plaintiffs were exposed to unsafe levels of PCBs at the Sky Valley Education Center (SVEC) or that any exposure could have possibly caused their claimed injuries," Bayer said in a statement.

"In reality, testing reflected extremely low levels of PCBs in this school."

PCBs were once used widely to insulate electrical equipment, and were also used in such products as carbonless copy paper, caulking, floor finish and paint. They were outlawed by the U.S. government in 1979 after being linked to cancer and other health problems. Monsanto produced PCBs from 1935 to 1977.

The plaintiffs had alleged exposure to PCB at the SVEC from fluorescent light ballasts, which Bayer said were produced decades ago by customers of Monsanto's products and installed in the late 1960s.

"These light ballasts were decades beyond their useful life, energy inefficient, and obsolete," Bayer said.

"These are historic claims that relate to products Monsanto has not produced in more than 40 years and are unrelated to any ongoing business of Monsanto, and now Bayer."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In December, a U.S. federal judge rejected Bayer's proposed $648 million settlement of separate class-action litigation by cities and other claimants over waste water contaminated with PCBs made by Monsanto.

Bayer has submitted a revised settlement to the court and is confident that it will be approved, a spokesperson for Bayer said. The company expects a decision on the matter this summer.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.